Anika Therapeutics, Inc.
ANIK· Nasdaq
ANIKAnika Therapeutics, Inc.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $29.77M | $26.96M | $29.39M | $28.73M |
| Net Income | $4.05M | $7.72M | $8.07M | $8.09M |
| EPS Diluted | $0.28 |
Anika Therapeutics, Inc. · CIK 898437 · Engraved from SEC EDGAR
| $0.54 |
| $0.53 |
| $0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
